Episurf Medical to present at Börsveckans Småbolagsdag, held in Stockholm, September 5

Episurf Medical will present at Börsveckans Småbolagsdag, a small-cap investor conference, held in Stockholm on September 5 (Operaterassen, Karl XII:s torg, Stockholm). The event is arranged by Financial Hearings and the company will be represented by CEO Pål Ryfors.

The presentation will be available on the company’s website after the presentation.

For full program and registration, see link. (https://financialhearings.com/event/9634)

For more  information, please contact:

Pål Ryfors, CEO, Episurf Medical

Tel:+46 (0) 709 62 36 69

Email: pal.ryfors@episurf.com

About Episurf Medical

Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and personalised treatment alternatives. Episurf Medical’s Episealer® personalised implants and Epiguide® surgical drill guides are developed for treating localized cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.